Evidence map›Paper›PMID 27277433›Full record

ArticleParasitology research2016

Effects of extracts from Echinacea purpurea (L) MOENCH on mice infected with different strains of Toxoplasma gondii.

Arquimedes Gasparotto Junior, Maria Luiza Antonio Cosmo, Michelle de Paula Reis, Pamela Secundo Dos Santos, Daniela Dib Gonçalves, Francielly Mourão Gasparotto, Italmar Teodorico Navarro, Emerson Luiz Botelho Lourenço

Abstract read
PubMed Publisher
In one paragraph

Article in Parasitology research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. The Search for Drugs Derived from Natural Products forCurrent topics in medicinal chemistry · 2024
    Pooled it
  2. Evaluation of Anti-Pharmaceuticals (Basel, Switzerland) · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Arquimedes Gasparotto JuniorLaboratory of Electrophysiology and Cardiovascular Pharmacology, Faculty of Health Sciences, Federal University of Grande Dourados, Rodovia Dourados-Itahum, km 12, P.O. Box 533, 79.804-970, Dourados, MS, Brazil. arquimedesgasparotto@gmail.com.
Maria Luiza Antonio CosmoLaboratory of Pharmacology and Toxicology of Natural Products, Universidade Paranaense, Umuarama, PR, Brazil.
Michelle de Paula ReisLaboratory of Pharmacology and Toxicology of Natural Products, Universidade Paranaense, Umuarama, PR, Brazil.
Pamela Secundo Dos SantosLaboratory of Pharmacology and Toxicology of Natural Products, Universidade Paranaense, Umuarama, PR, Brazil.
Daniela Dib GonçalvesLaboratory of Pharmacology and Toxicology of Natural Products, Universidade Paranaense, Umuarama, PR, Brazil.
Francielly Mourão GasparottoLaboratory of Electrophysiology and Cardiovascular Pharmacology, Faculty of Health Sciences, Federal University of Grande Dourados, Rodovia Dourados-Itahum, km 12, P.O. Box 533, 79.804-970, Dourados, MS, Brazil.
Italmar Teodorico NavarroAnimal Science Department, Londrina State University, Londrina, PR, Brazil.
Emerson Luiz Botelho LourençoLaboratory of Pharmacology and Toxicology of Natural Products, Universidade Paranaense, Umuarama, PR, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, due to the growing concern about recurrent epidemics by Toxoplasma gondii and other pathogens in Brazil, there has been an increase in the use of different preparations obtained from Echinacea purpurea in order to test their effectiveness against these infections. Although studies have suggested the beneficial effects of this species against the influenza virus, no data are available on the use of E. purpurea aqueous extract in T. gondii infections. Thus, the aim of this study was to analyze the effect of its administration in Swiss mice submitted to acute and prolonged infection with different T. gondii strains. This study showed that E. purpurea extract induced a significant reduction in the number of tachyzoites in the peritoneal fluid and liver imprints from mice infected by the RH strain. Moreover, prolonged treatment significantly increased the number of brain cysts of animals infected with ME 49 strain. The results obtained in this study suggest that the crude extract obtained from E. purpurea has important protective activities against infection with different T. gondii strains.

Indexed as

AnimalsAscitic FluidBrazilDisease Models, AnimalEchinaceaFlowersImmunomodulationLiverMaleMicePlant ExtractsToxoplasmaToxoplasmosisPlant ExtractsEchinacea purpureaImmunomodulatoryInfectionToxoplasma gondii

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.